In the past couple of decades, the utilization of absorbable polymers has been burgeoning in the biomedical implant and drug delivery industry. These polymers eliminate the need for surgically removing the implants and improve their tensile strength throughout the healing phase of the laceration. Owing to their composition, such implants are degradable by tissues metabolism, resulting in faster and efficient healing. At the forefront of developing such innovative implantable devices that are redefining the status quo of the biomedical industry is Bezwada Biomedical. Under the leadership of Dr. Rao S. Bezwada, a pioneer and accomplished professional in the field with over 142 US patents under his name, the firm develops a wide range of ingenious and proprietary absorbable monomers and polymers that are employed across different biomedical processes and next-generation medical devices, enhancing quality of life.